Skip to main content

Legal signal newsroom

Life Sciences insights

Articles on life sciences law in China — practical guidance for foreign clients.

01Editorially selectedPractical impact before publishing order.
02Published vs updatedDates map to verified content fields.
03Bridge to evergreen researchInsights lead back to durable guides.

Archive dispatches

Latest legal signals

12 analyses on this page.

Life Sciences
Legally reviewed · 8 Aug 2026

China Drug Patent Linkage: Building a Category-Style Challenge Watch for Originators

8 min readRead analysis →
Life Sciences
Legally reviewed · 8 Aug 2026

After an FDA Warning Letter: Aligning Customer Notices with CAPA (Without Creating New Lies)

10 min readRead analysis →
Life Sciences
Legally reviewed · 8 Aug 2026

Internet Hospital KOL Scripts: Medical-Legal Approval Before the Livestream Goes Live

9 min readRead analysis →
Life Sciences
Legally reviewed · 8 Aug 2026

PI Protocol Deviations in China Trials: Splitting Sponsor, Hospital, and Investigator Risk

10 min readRead analysis →
Life Sciences
Legally reviewed · 8 Aug 2026

Royalty Audits on China License Deals: When Sales Live in WeChat and Tender Files

9 min readRead analysis →
Life Sciences
Legally reviewed · 8 Aug 2026

Medical Device Design-Around in China: FTO Notes That Engineering Will Actually Use

10 min readRead analysis →
Life Sciences
Legally reviewed · 8 Aug 2026

Residual Clinical Samples in China: Secondary Research Without Creating an HGR Surprise

10 min readRead analysis →
Life Sciences
Legally reviewed · 8 Aug 2026

Academic Conference Speaker Fees in China Healthcare: An FMV File That Survives Scrutiny

9 min readRead analysis →
Life Sciences
Legally reviewed · 8 Aug 2026

Two-Invoice Pressure After VBP: Redesigning Pharma Device Channels Without Building a Paper CSO

9 min readRead analysis →
Life Sciences
Legally reviewed · 8 Aug 2026

Health Data Anonymisation in China: Why “We Hashed the Name” Usually Fails the Legal Standard

9 min readRead analysis →
Life Sciences
Legally reviewed · 8 Aug 2026

Real-World Evidence Projects in China: Privacy and Secondary-Use Traps for Global RWE Teams

10 min readRead analysis →
Life Sciences
Legally reviewed · 8 Aug 2026

Implant Fracture Claims in China: Dual-Track Appraisal Strategy for Manufacturers

8 min readRead analysis →

Signal to framework

A development is useful only when you can place it in the wider legal framework.

Use the national guides for the durable architecture behind a news event, then return here when a development changes the practical question.

Explore legal guides →